Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 86 articles:
HTML format
Text format



Single Articles


    April 2017
  1. MELNYCHUK L, Ajamian L, Jean-Pierre P, Liang J, et al
    Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region.
    Vaccine. 2017 Apr 6. pii: S0264-410X(17)30355.
    PubMed     Text format     Abstract available


    March 2017
  2. TANG X, Guo J, Cheng L, Sun C, et al
    Single N277A substitution in C2 of simian immunodeficiency virus envelope influences vaccine-elicited CD4i neutralizing and anti-V2 antibody responses.
    Vaccine. 2017 Mar 30. pii: S0264-410X(17)30389.
    PubMed     Text format     Abstract available


  3. SHI J, Feng Y, Gao L, Feng D, et al
    Immunogenicity and safety of a high-dose hepatitis B vaccine among patients receiving methadone maintenance treatment: A randomized, double-blinded, parallel-controlled trial.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30340.
    PubMed     Text format     Abstract available


  4. VAN REGENMORTEL MH
    Immune systems rather than antigenic epitopes elicit and produce protective antibodies against HIV.
    Vaccine. 2017 Mar 17. pii: S0264-410X(17)30323.
    PubMed     Text format    


  5. HUANG X, Zhu Q, Huang X, Yang L, et al
    In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses.
    Vaccine. 2017 Mar 16. pii: S0264-410X(17)30312.
    PubMed     Text format     Abstract available


  6. SEIB K, Pollard AJ, de Wals P, Andrews RM, et al
    Policy making for vaccine use as a driver of vaccine innovation and development in the developed world.
    Vaccine. 2017;35:1380-1389.
    PubMed     Text format     Abstract available


  7. SETH L, Bingham Ferlez KM, Kaba SA, Musser DM, et al
    Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants.
    Vaccine. 2017 Mar 5. pii: S0264-410X(17)30243.
    PubMed     Text format     Abstract available


  8. GIERSING BK, Vekemans J, Nava S, Kaslow DC, et al
    Report from the World Health Organization's third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016.
    Vaccine. 2017 Mar 2. pii: S0264-410X(16)31205.
    PubMed     Text format     Abstract available


    February 2017
  9. LEVIN MJ, Huang S, Moscicki AB, Song LY, et al
    Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine.
    Vaccine. 2017 Feb 23. pii: S0264-410X(17)30215.
    PubMed     Text format     Abstract available


  10. BALASUBRAMANIAN P, Kumar R, Williams C, Itri V, et al
    Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination.
    Vaccine. 2017 Feb 6. pii: S0264-410X(17)30089.
    PubMed     Text format     Abstract available


    January 2017
  11. HUANG Y, Zhang L, Janes H, Frahm N, et al
    Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials.
    Vaccine. 2017 Jan 25. pii: S0264-410X(16)30879.
    PubMed     Text format     Abstract available


  12. ABARA WE, Collier MG, Teshale EH
    Impact of universal infant hepatitis B vaccination in the US-affiliated Pacific Islands, 1985-2015.
    Vaccine. 2017 Jan 20. pii: S0264-410X(17)30039.
    PubMed     Text format     Abstract available


  13. HOEST C, Seidman JC, Lee G, Platts-Mills JA, et al
    Vaccine coverage and adherence to EPI schedules in eight resource poor settings in the MAL-ED cohort study.
    Vaccine. 2017;35:443-451.
    PubMed     Text format     Abstract available


  14. CHEGE GK, Burgers WA, Muller TL, Gray CM, et al
    DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31294.
    PubMed     Text format     Abstract available


  15. BREWER MG, DiPiazza A, Acklin J, Feng C, et al
    Nanoparticles decorated with viral antigens are more immunogenic at low surface density.
    Vaccine. 2017 Jan 3. pii: S0264-410X(16)31274.
    PubMed     Text format     Abstract available


    December 2016
  16. MATTHIESSEN L, Lang H, Klimathianaki M, Hanrahan F, et al
    European strategy for vaccine development against infectious diseases.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)30952.
    PubMed     Text format     Abstract available


  17. POWELL AM, Luo Z, Martin L, Wan Z, et al
    The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31233.
    PubMed     Text format     Abstract available


  18. RUAN S, Cai Y, Ramsay AJ, Welsh DA, et al
    B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection.
    Vaccine. 2016 Dec 21. pii: S0264-410X(16)31144.
    PubMed     Text format     Abstract available


  19. MOSERI A, Sinha E, Zommer H, Arshava B, et al
    Immunofocusing using conformationally constrained V3 peptide immunogens improves HIV-1 neutralization.
    Vaccine. 2016 Dec 7. pii: S0264-410X(16)31178.
    PubMed     Text format     Abstract available


    November 2016
  20. POTEET E, Lewis P, Chen C, Ho SO, et al
    Toll-like receptor 3 adjuvant in combination with virus-like particles elicit a humoral response against HIV.
    Vaccine. 2016;34:5886-5894.
    PubMed     Text format     Abstract available


  21. ALLEMAN MM, Wannemuehler KA, Hao L, Perelygina L, et al
    Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)30994.
    PubMed     Text format     Abstract available


  22. PEREIRA-MANFRO WF, Alvino RM, Cruz AC, Silva GP, et al
    Association of serum bactericidal antibody and opsonic antibody levels after Neisseria meningitidis serogroup C conjugate vaccine in Brazilian children and adolescents infected or not infected with HIV.
    Vaccine. 2016 Nov 12. pii: S0264-410X(16)31042.
    PubMed     Text format     Abstract available


  23. YU HT, Wang JY, Tian D, Wang MX, et al
    Comparison of the patterns of antibody recall responses to HIV-1 gp120 and hepatitis B surface antigen in immunized mice.
    Vaccine. 2016 Nov 11. pii: S0264-410X(16)30998.
    PubMed     Text format     Abstract available


  24. FONTENOT HB, Fantasia HC, Vetters R, Zimet GD, et al
    Increasing HPV vaccination and eliminating barriers: Recommendations from young men who have sex with men.
    Vaccine. 2016 Nov 9. pii: S0264-410X(16)31026.
    PubMed     Text format     Abstract available


    October 2016
  25. HERTZ T, Logan MG, Rolland M, Magaret CA, et al
    A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial.
    Vaccine. 2016 Oct 15. pii: S0264-410X(16)30880.
    PubMed     Text format     Abstract available


  26. BAMFORD A, Manno EC, Mellado MJ, Spoulou V, et al
    Immunisation practices in centres caring for children with perinatally acquired HIV: A call for harmonisation.
    Vaccine. 2016 Oct 7. pii: S0264-410X(16)30848.
    PubMed     Text format     Abstract available


  27. ABADOM TR, Smith AD, Tempia S, Madhi SA, et al
    Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: A case-population study.
    Vaccine. 2016 Oct 6. pii: S0264-410X(16)30824.
    PubMed     Text format     Abstract available


    September 2016
  28. GIRARD MP, Le-Grand R, Picot V, Longuet C, et al
    Report of the Cent Gardes HIV Vaccines Conference, Part 2: The cellular immune response. Fondation Merieux Conference Center, Veyrier-du-Lac, France, 25-27 October 2015.
    Vaccine. 2016 Sep 27. pii: S0264-410X(16)30847.
    PubMed     Text format    


  29. HOLECHEK SA, McAfee MS, Nieves LM, Guzman VP, et al
    Retinaldehyde dehydrogenase 2 as a molecular adjuvant for enhancement of mucosal immunity during DNA vaccination.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30826.
    PubMed     Text format     Abstract available


  30. DZANIBE S, Adrian PV, Kimaro Mlacha SZ, Madhi SA, et al
    Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children.
    Vaccine. 2016 Sep 20. pii: S0264-410X(16)30828.
    PubMed     Text format     Abstract available


  31. MUNIER CM, van Bockel D, Bailey M, Ip S, et al
    The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype.
    Vaccine. 2016 Sep 14. pii: S0264-410X(16)30805.
    PubMed     Text format     Abstract available


  32. ANDERSSON AC, Ragonnaud E, Seaton KE, Sawant S, et al
    Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.
    Vaccine. 2016 Sep 12. pii: S0264-410X(16)30798.
    PubMed     Text format     Abstract available


    August 2016
  33. CRUM-CIANFLONE NF, Won S, Lee R, Lalani T, et al
    Vitamin D levels and influenza vaccine immunogenicity among HIV-infected and HIV-uninfected adults.
    Vaccine. 2016 Aug 28. pii: S0264-410X(16)30432.
    PubMed     Text format     Abstract available


  34. PENALOZA-MACMASTER P, Alayo QA, Ra J, Provine NM, et al
    Inhibitory receptor expression on memory CD8 T cells following Ad vector immunization.
    Vaccine. 2016 Aug 24. pii: S0264-410X(16)30733.
    PubMed     Text format     Abstract available


  35. MORO PL, Chen RT
    Obstetrical and neonatal case definitions for immunization safety data.
    Vaccine. 2016 Aug 20. pii: S0264-410X(16)30698.
    PubMed     Text format    


  36. SUMNER RP, Ren H, Ferguson BJ, Smith GL, et al
    Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators.
    Vaccine. 2016 Aug 17. pii: S0264-410X(16)30659.
    PubMed     Text format     Abstract available


  37. MONEY DM, Moses E, Blitz S, Vandriel SM, et al
    HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine.
    Vaccine. 2016 Aug 17. pii: S0264-410X(16)30673.
    PubMed     Text format     Abstract available


  38. WESTMAN ME, Malik R, Hall E, Harris M, et al
    The protective rate of the feline immunodeficiency virus vaccine: An Australian field study.
    Vaccine. 2016 Aug 10. pii: S0264-410X(16)30511.
    PubMed     Text format     Abstract available


  39. LI X, Huang J, Zhang M, Funakoshi R, et al
    Human CD8+ T cells mediate protective immunity induced by a human malaria vaccine in human immune system mice.
    Vaccine. 2016 Aug 5. pii: S0264-410X(16)30663.
    PubMed     Text format     Abstract available


    July 2016
  40. HERATH S, Le Heron A, Colloca S, Patterson S, et al
    Strain-dependent and distinctive T-cell responses to HIV antigens following immunisation of mice with differing chimpanzee adenovirus vaccine vectors.
    Vaccine. 2016 Jul 21. pii: S0264-410X(16)30611.
    PubMed     Text format     Abstract available


  41. CLARKE DK, Hendry RM, Singh V, Rose JK, et al
    Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.
    Vaccine. 2016 Jul 6. pii: S0264-410X(16)30548.
    PubMed     Text format     Abstract available


  42. RITZ N, Casalaz D, Donath S, Tebruegge M, et al
    Comparable CD4 and CD8 T cell responses and cytokine release after at-birth and delayed BCG immunisation in infants born in Australia.
    Vaccine. 2016 Jul 5. pii: S0264-410X(16)30557.
    PubMed     Text format     Abstract available


    June 2016
  43. CONDIT RC, Williamson AL, Sheets R, Seligman SJ, et al
    Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains.
    Vaccine. 2016 Jun 23. pii: S0264-410X(16)30225.
    PubMed     Text format     Abstract available


  44. WIYSONGE CS, Waggie Z, Hawkridge A, Schoub BD, et al
    The Cape Town Declaration on Vaccines 2012: Unlocking the full potential of vaccines in Africa.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30398.
    PubMed     Text format     Abstract available


  45. ABDULLAHI LH, Kagina BM, Cassidy T, Adebayo EF, et al
    Knowledge, attitudes and practices on adolescent vaccination among adolescents, parents and teachers in Africa: A systematic review.
    Vaccine. 2016 Jun 8. pii: S0264-410X(16)30437.
    PubMed     Text format     Abstract available


    May 2016
  46. GIRARD MP, Le-Grand R, Picot V, Longuet C, et al
    Report of the Cent Gardes HIV Vaccines Conference. Part 1: The antibody response; Fondation Merieux Conference Center, Veyrier-du-Lac, France, 25-27 October 2015.
    Vaccine. 2016 May 20. pii: S0264-410X(16)30314.
    PubMed     Text format     Abstract available


  47. THORNE A, Chowdhury F, Singer J, Keynan Y, et al
    Comparison of hemagglutination inhibition and microbead array assays for the measurement of influenza antibody levels in HIV-infected adults.
    Vaccine. 2016 May 19. pii: S0264-410X(16)30310.
    PubMed     Text format     Abstract available


  48. ZHANG Q, Liu Z, Hou J, Wang S, et al
    Improved safety of a replication-competent poxvirus-based HIV vaccine with the introduction of the HSV-TK/GCV suicide gene system.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30295.
    PubMed     Text format     Abstract available


  49. ASTURIAS EJ, Wharton M, Pless R, MacDonald NE, et al
    Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30301.
    PubMed     Text format     Abstract available


  50. VENEREO-SANCHEZ A, Gilbert R, Simoneau M, Caron A, et al
    Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30264.
    PubMed     Text format     Abstract available


  51. ALDHAMEN YA, Rastall DP, Chen W, Seregin SS, et al
    CRACC-targeting Fc-fusion protein induces activation of NK cells and DCs and improves T cell immune responses to antigenic targets.
    Vaccine. 2016 May 3. pii: S0264-410X(16)30233.
    PubMed     Text format     Abstract available


    April 2016
  52. HAKIM H, Allison KJ, Van de Velde LA, Tang L, et al
    Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection.
    Vaccine. 2016 Apr 26. pii: S0264-410X(16)30207.
    PubMed     Text format     Abstract available


  53. GOTTLIEB SL, Deal CD, Giersing B, Rees H, et al
    The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps.
    Vaccine. 2016 Apr 19. pii: S0264-410X(16)30170.
    PubMed     Text format     Abstract available


  54. HESSELL AJ, McBurney S, Pandey S, Sutton W, et al
    Induction of neutralizing antibodies in rhesus macaques using V3 mimotope peptides.
    Vaccine. 2016 Apr 19. pii: S0264-410X(16)30165.
    PubMed     Text format     Abstract available


  55. ZHOU S, Liu Q, Wu X, Chen P, et al
    A safe and sensitive enterovirus A71 infection model based on human SCARB2 knock-in mice.
    Vaccine. 2016 Apr 18. pii: S0264-410X(16)30167.
    PubMed     Text format     Abstract available


  56. MODJARRAD K
    MERS-CoV vaccine candidates in development: The current landscape.
    Vaccine. 2016 Apr 12. pii: S0264-410X(16)30101.
    PubMed     Text format     Abstract available


  57. WILLIAMS EA, Lewis DJ, Bertholet S, Zazzi M, et al
    Anticipating policy considerations for a future HIV vaccine: a preliminary study.
    Vaccine. 2016 Apr 4. pii: S0264-410X(16)30083.
    PubMed     Text format     Abstract available


  58. HESSELING AC, Blakney AK, Jones CE, Esser MM, et al
    Delayed BCG immunization does not alter antibody responses to EPI vaccines in HIV-exposed and -unexposed South African infants.
    Vaccine. 2016 Apr 4. pii: S0264-410X(16)30078.
    PubMed     Text format     Abstract available


    March 2016
  59. PRIYA RS, Menon V, Priyanka D, Pal R, et al
    Membrane bound Indian clade C HIV-1 envelope antigen induces antibodies to diverse and conserved epitopes upon DNA prime/protein boost in rabbits.
    Vaccine. 2016 Mar 28. pii: S0264-410X(16)30058.
    PubMed     Text format     Abstract available


  60. WALSH DS, Owira V, Polhemus M, Otieno L, et al
    Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON-TB Gold (+) Kenyan adults without evidence of tuberculosis.
    Vaccine. 2016 Mar 26. pii: S0264-410X(16)30065.
    PubMed     Text format     Abstract available


  61. GARTLAN KH, Krashias G, Wegmann F, Hillson WR, et al
    Sterile inflammation induced by Carbopol elicits robust adaptive immune responses in the absence of pathogen-associated molecular patterns.
    Vaccine. 2016 Mar 19. pii: S0264-410X(16)00336.
    PubMed     Text format     Abstract available


  62. GAGNEUX-BRUNON A, Lucht F, Botelho-Nevers E
    HIV care: A missed opportunity for immunization.
    Vaccine. 2016 Mar 18. pii: S0264-410X(16)00335.
    PubMed     Text format    


  63. TUNG FY, Tung JK, Pallikkuth S, Pahwa S, et al
    A therapeutic HIV-1 vaccine enhances anti-HIV-1 immune responses in patients under highly active antiretroviral therapy.
    Vaccine. 2016 Mar 18. pii: S0264-410X(16)00332.
    PubMed     Text format     Abstract available


  64. NICOLI F, Gallerani E, Skarlis C, Sicurella M, et al
    Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection.
    Vaccine. 2016 Mar 18. pii: S0264-410X(16)00333.
    PubMed     Text format     Abstract available


  65. GRABMEIER-PFISTERSHAMMER K, Burgmann H, Poeppl W
    To the editor Re: HIV care: A missed opportunity for immunization.
    Vaccine. 2016 Mar 17. pii: S0264-410X(16)00334.
    PubMed     Text format    


  66. GIERSING BK, Modjarrad K, Kaslow DC, Moorthy VS, et al
    Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7-9th Sep 2015.
    Vaccine. 2016 Mar 15. pii: S0264-410X(16)00291.
    PubMed     Text format     Abstract available


  67. SAFRIT JT, Fast PE, Gieber L, Kuipers H, et al
    Status of vaccine research and development of vaccines for HIV-1.
    Vaccine. 2016 Mar 15. pii: S0264-410X(16)00280.
    PubMed     Text format     Abstract available


  68. ARYA BK, Bhattacharya SD, Sutcliffe CG, Saha MK, et al
    Immunogenicity and safety of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine in Indian children living with HIV.
    Vaccine. 2016 Mar 14. pii: S0264-410X(16)00302.
    PubMed     Text format     Abstract available


  69. JOHNSTON C, Gottlieb SL, Wald A
    Status of vaccine research and development of vaccines for herpes simplex virus prepared for WHO PD-VAC.
    Vaccine. 2016 Mar 10. pii: S0264-410X(16)00297.
    PubMed     Text format     Abstract available


  70. STORCKSDIECK GENANNT BONSMANN , Niezold T, Hannaman D, Uberla K, et al
    The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8 T cell responses.
    Vaccine. 2016 Mar 3. pii: S0264-410X(16)00254.
    PubMed     Text format     Abstract available


  71. FUSTER F, Vargas JI, Jensen D, Sarmiento V, et al
    CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study.
    Vaccine. 2016 Mar 2. pii: S0264-410X(16)00236.
    PubMed     Text format     Abstract available


    February 2016
  72. ABAASA A, Asiki G, Price MA, Ruzagira E, et al
    Comparison of HIV incidence estimated in clinical trial and observational cohort settings in a high risk fishing population in Uganda: Implications for sample size estimates.
    Vaccine. 2016 Feb 25. pii: S0264-410X(16)00229.
    PubMed     Text format     Abstract available


  73. FAUST H, Toft L, Sehr P, Muller M, et al
    Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccines.
    Vaccine. 2016 Feb 16. pii: S0264-410X(16)00161.
    PubMed     Text format     Abstract available


  74. FOWLKES AL, Witte D, Beeler J, Audet SA, et al
    Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules.
    Vaccine. 2016 Feb 9. pii: S0264-410X(16)00118.
    PubMed     Text format     Abstract available


    January 2016
  75. TAN HX, Gilbertson BP, Jegaskanda S, Alcantara S, et al
    Recombinant influenza virus expressing HIV-1 p24 capsid protein induces mucosal HIV-specific CD8 T-cell responses.
    Vaccine. 2016 Jan 28. pii: S0264-410X(16)00074.
    PubMed     Text format     Abstract available


  76. HUANG Y, Zhang L, Jolliffe D, Hovden AO, et al
    A case for preART-adjusted endpoints in HIV therapeutic vaccine trials.
    Vaccine. 2016 Jan 27. pii: S0264-410X(16)00069.
    PubMed     Text format     Abstract available


  77. ARANYOS AM, Roff SR, Pu R, Owen JL, et al
    An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection.
    Vaccine. 2016 Jan 20. pii: S0264-410X(16)00043.
    PubMed     Text format     Abstract available


  78. AHMED T, Borthwick NJ, Gilmour J, Hayes P, et al
    Control of HIV-1 replication in vitro by vaccine-induced human CD8 T cells through conserved subdominant Pol epitopes.
    Vaccine. 2016 Jan 16. pii: S0264-410X(15)01793.
    PubMed     Text format     Abstract available


    December 2015
  79. LUO Z, Ma L, Zhang L, Martin L, et al
    Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.
    Vaccine. 2015 Dec 22. pii: S0264-410X(15)01835.
    PubMed     Text format     Abstract available


  80. OHTOLA JA, Khaskhely NM, Saul-Mcbeth JL, Iyer AS, et al
    Alterations in serotype-specific B cell responses to the 13-valent pneumococcal conjugate vaccine in aging HIV-infected adults.
    Vaccine. 2015 Dec 18. pii: S0264-410X(15)01785.
    PubMed     Text format     Abstract available


  81. KARDANI K, Bolhassani A, Shahbazi S
    Prime-boost vaccine strategy against viral infections: Mechanisms and benefits.
    Vaccine. 2015 Dec 12. pii: S0264-410X(15)01743.
    PubMed     Text format     Abstract available


  82. CHONWATTANA W, Raengsakulrach B, Holtz TH, Wasinrapee P, et al
    Hepatitis B vaccination uptake and correlates of serologic response among HIV-infected and uninfected men who have sex with men (MSM) in Bangkok, Thailand.
    Vaccine. 2015 Dec 9. pii: S0264-410X(15)01765.
    PubMed     Text format     Abstract available


  83. HARIRI S, Markowitz LE, Unger ER
    Response to Pendleton et al. regarding reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States.
    Vaccine. 2015 Dec 2. pii: S0264-410X(15)01608.
    PubMed     Text format    


    November 2015
  84. HERATH S, Le Heron A, Colloca S, Bergin P, et al
    Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag-pol-nef antigen.
    Vaccine. 2015 Nov 4. pii: S0264-410X(15)01567.
    PubMed     Text format     Abstract available


    October 2015
  85. TRIVEDI S, Neeman T, Jackson RJ, Ranasinghe R, et al
    Identification of biomarkers to measure HIV-specific mucosal and systemic CD8 T-cell immunity using single cell Fluidigm 48.48 Dynamic arrays.
    Vaccine. 2015 Oct 28. pii: S0264-410X(15)01528.
    PubMed     Text format     Abstract available


  86. CHENG C, Wang L, Ko SY, Kong WP, et al
    Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development.
    Vaccine. 2015 Oct 26. pii: S0264-410X(15)01438.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: